These findings suggest that exogenous CB1 agonism is implied in the cognitive impairments of schizophrenia, and that this disruption seems to involve both the eCB system and the glutamatergic neurotransmission (Roser et al., 2011). The gene discussed is CNR1; the disease is schizophrenia.